
    
      A Multi-Centre, Multi-country, Randomized, Double-Blind (Subject, Investigator),
      Placebo-Controlled, Repeat-Dose study to evaluate the Efficacy and Safety of Intravenous
      GSK679586 in Patients with Severe Asthma
    
  